The U.K. and China will be the biggest beneficiaries of the U.S. health secretary’s “own goal” of pulling funding for mRNA vaccines, according to experts. Robert…
Unlock the White House Watch newsletter for freeYour guide to what Trump’s second term means for Washington, business and the worldShares of biotech companies endured volatile…
The live music, free drinks and dancing at a big Boston biotech conference in June belied a stark reality: the city’s biotech sector is in trouble.While…
Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its…
